Vimarsana
Biggest News Aggregation in the World

Page 24 - Services Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Services Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Services Inc Today - Breaking & Trending Today

West Pharmaceutical Services Q1 Net Income Declines; Increases 2024 Adj. EPS Guidance - Vimarsana News

West Pharmaceutical Services Q1 Net Income Declines; Increases 2024 Adj. EPS Guidance

West Pharmaceutical Services, Inc. (WST) reported that its first quarter net income was $115.3 million, compared to $140.0 million, prior year. Reported EPS was $1.

West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend - Vimarsana News

West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., April 25, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. today announced its financial results for the first-quarter 2024 and...

West Pharmaceutical Services (NYSE:WST) Updates FY 2024 Earnings Guidance - Vimarsana News

West Pharmaceutical Services (NYSE:WST) Updates FY 2024 Earnings Guidance

West Pharmaceutical Services (NYSE:WST – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 7.630-7.880 for the period, compared to the consensus earnings per share estimate of 7.620. The company issued revenue guidance of $3.0 billion-$3.0 billion, compared to the consensus revenue estimate of $3.0 […]

Source: wkrb13.com
West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak - Vimarsana News

West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak

West Pharmaceutical Services, Inc. WST reported first-quarter 2024 adjusted earnings per share EPS of $1.56, which beat the Zacks Consensus Estimate by 20.9%.…

Source: biztoc.com
West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak - Becton Dickinson (NYSE:BDX), Ecolab (NYSE:ECL) - Vimarsana News

West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak - Becton Dickinson (NYSE:BDX), Ecolab (NYSE:ECL)

West Pharmaceutical Services, Inc. (NYSE: WST) reported first-quarter 2024 adjusted earnings per share (ETF:EPS) of $1.56, which beat the Zacks Consensus Estimate by 20.9%. The bottom line, however, was down 21.2% year over year.